The Rodenstock Company
At the heart of Rodenstock's business strategy is the patented DNEye® Pro technology, with which Rodenstock is the first company to measure the individual shape and size of each eye and produce individualised spectacle lenses, so-called Biometric Intelligent Glasses (B.I.G. VISION™), from thousands of data points.
In addition to this competence, Rodenstock also stands for German engineering with the highest quality in the field of spectacle frames.
Founded in 1877 and headquartered in Munich, Germany, the company employs about 5,100 people worldwide and is represented by sales offices and distribution partners in more than 85 countries. Rodenstock maintains production facilities at a total of 16 locations in 15 countries.
Our Board
Rodenstock is led by an experienced management team.
Marcus Desimoni
• With Rodenstock since 2021
• Has held leading positions in various companies and countries: Siemens, Sivantos Audiology, GN Hearing
• More than 20 years of experience
To be announced soon
Roland Dimbath
• With Rodenstock since 2006
• Previously worked at Rodenstock as Head of Sales and Operations Eastern Europe and Head of Logistics and Purchasing
• More than 20 years of experience
Dr. Dietmar Uttenweiler
• With Rodenstock since 2003
• Long-standing Rodenstock employee with extensive professional experience and expertise
• More than 20 years of experience
Martin R. Lange
• With Rodenstock since 2022
• Worked in various sales and marketing leadership positions with global medtech / healthcare companies
• More than 20 years of experience
Our corporate structure
In 2002, Rodenstock set the course towards a corporate structure suitable for the capital market by transforming into a GmbH (limited liability company). In June 2003, Permira Beteiligungsberatung GmbH became the first non-family financial investor. In 2007, the European investment company Bridgepoint took over the shares held by the Permira funds. In 2015, Compass Partners joined Rodenstock as an additional investor.
Apax Funds acquired their shares in March 2021. Apax Funds will support Rodenstock's management in accelerating the company's growth and driving innovation, digitalisation and effective marketing of its products.
You will shortly receive an email confirming the data that has been sent to the optician. The optician will contact you directly to set-up your appointment.
BACK TO HOMEPlease try again.